Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13934
Country/Region: Ethiopia
Year: 2015
Main Partner: Addis Ababa Health Bureau
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $6,427,799 Additional Pipeline Funding: $60,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $660,000
Care: TB/HIV (HVTB) $150,000
Care: Pediatric Care and Support (PDCS) $100,000
Laboratory Infrastructure (HLAB) $90,000
Strategic Information (HVSI) $134,900
Health Systems Strengthening (OHSS) $40,000
Biomedical Prevention: Blood Safety (HMBL) $37,540
Testing: HIV Testing and Counseling (HVCT) $125,034
Sexual Prevention: Other Sexual Prevention (HVOP) $90,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $550,000
Treatment: Adult Treatment (HTXS) $3,950,000
Treatment: Pediatric Treatment (PDTX) $500,325
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 78,804
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 10,519
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 1,957
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 6,159
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 39,032
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 45,846
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 260,561
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 134,496
HTS_TST By Test Result: Negative 2016 462,451
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 479,935
HTS_TST Sum of Aggregated Age/Sex <15 2016 84,878
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 395,057
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 479,935
HTS_TST Sum of Test Result disaggregates 2016 479,935
HTS_TST_POS By Test Result: Positive 2016 17,484
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 12
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 130
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 3,929
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 3,674
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 2,387
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 1,287
PMTCT_ARV Sum of New and Current disaggregates 2016 3,674
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 3,394
PMTCT_STAT By: Known positives at entry 2016 2,772
PMTCT_STAT By: Number of new positives identified 2016 1,189
PMTCT_STAT Number of new ANC and L&D clients 2016 88,483
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 84,056
PMTCT_STAT Sum of Positives Status disaggregates 2016 3,961
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 78,804
TX_CURR Age/Sex: <1 Female 2016 165
TX_CURR Age/Sex: <1 Male 2016 202
TX_CURR Age/Sex: 1-4 Female 2016 615
TX_CURR Age/Sex: 1-4 Male 2016 695
TX_CURR Age/Sex: 5-14 Female 2016 1,228
TX_CURR Age/Sex: 5-14 Male 2016 1,183
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 69,541
TX_CURR Sum of age/sex disaggregates 2016 69,541
TX_NEW By Age/Sex: <1 Female 2016 28
TX_NEW By Age/Sex: <1 Male 2016 35
TX_NEW By Age/Sex: 1-4 Female 2016 81
TX_NEW By Age/Sex: 1-4 Male 2016 111
TX_NEW By Age/Sex: 10-14 Female 2016 60
TX_NEW By Age/Sex: 10-14 Male 2016 60
TX_NEW By Age/Sex: 15-19 Female 2016 123
TX_NEW By Age/Sex: 15-19 Male 2016 50
TX_NEW By Age/Sex: 20-24 Female 2016 957
TX_NEW By Age/Sex: 20-24 Male 2016 188
TX_NEW By Age/Sex: 25-49 Female 2016 4,839
TX_NEW By Age/Sex: 25-49 Male 2016 2,717
TX_NEW By Age/Sex: 5-9 Female 2016 104
TX_NEW By Age/Sex: 5-9 Male 2016 118
TX_NEW By Age/Sex: 50+ Female 2016 113
TX_NEW By Age/Sex: 50+ Male 2016 313
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 9,897
TX_NEW Sum of Age/Sex disaggregates 2016 9,897
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 8,548
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 10,054
Cross Cutting Budget Categories and Known Amounts Total: $1,264,834
Renovation $347,334
Human Resources for Health $325,000
Gender: Gender Based Violence (GBV) $32,500
GBV Prevention
Implementation
Post GBV Care
Capacity building
Key Populations: Sex Workers $65,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Food and Nutrition: Policy, Tools, and Service Delivery $65,000
Water $32,500
Condoms: Policy, Tools, and Services $32,500
Education $65,000
Motor Vehicles: Purchased $300,000